Probiotics Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035
The market opportunity associated Probiotics Market is anticipated to witness a CAGR of 8.0% over the next decade. The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035.
Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
Furthermore, the global market opportunity is expected to be well-distributed across different market segmentations, including different food and beverage products, food and beverages, ingredients, end user and distribution channels. Presently, the probiotics for humans capture the highest probiotics market share and are likely to remain the same during the forecast period.
In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel probiotics that can be consumed by various human population
The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different companies having probiotic portfolio. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one company is better than another.
The following approach was adopted to compare the key probiotic companies in the market:
• As a starting point, we collated information on the aforementioned parameters for key companies that are involved in the offering probiotics, and thus, were considered for this analysis.
• The probiotic companies were segregated across three peer groups based on their company size, including mid-sized, large and very large companies.
Further, company competitiveness was assessed score for companies using company strength (in terms of number of years since its establishment) and portfolio strength (based on number of probiotic brands, type of probiotic, target human population, end user and type of ingredient).
More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/probiotics-market.html
Probiotics Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035
The market opportunity associated Probiotics Market is anticipated to witness a CAGR of 8.0% over the next decade. The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035.
Using our proprietary methodology, we have provided informed projections, describing the likely growth of the opportunity associated with the probiotics market. As per the base case forecast scenario, the probiotic market size is estimated to grow at a CAGR of 8.0%, during the forecast period. The market growth of this industry is believed to be primarily driven by the numerous advantages offered by probiotics for prevention and treatment of diseases. This is anticipated to sustain the demand for various types of probiotics, resulting in lucrative monetization opportunities for probiotic companies.
It is worth mentioning that according to our projections, Asia Pacific is likely to capture the majority (more than 45%) of the overall market share, and this trend is unlikely to change in the future, as well. It is worth highlighting that the global market in Latin America is expected to grow at a relatively healthy CAGR, during the forecast period. Further, it is worth mentioning that, as per the probiotics market segmentation, probiotic dietary supplements segment in the probiotics market is anticipated to grow at a higher CAGR, during the forecast period.
Furthermore, the global market opportunity is expected to be well-distributed across different market segmentations, including different food and beverage products, food and beverages, ingredients, end user and distribution channels. Presently, the probiotics for humans capture the highest probiotics market share and are likely to remain the same during the forecast period.
In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel probiotics that can be consumed by various human population
The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different companies having probiotic portfolio. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one company is better than another.
The following approach was adopted to compare the key probiotic companies in the market:
• As a starting point, we collated information on the aforementioned parameters for key companies that are involved in the offering probiotics, and thus, were considered for this analysis.
• The probiotic companies were segregated across three peer groups based on their company size, including mid-sized, large and very large companies.
Further, company competitiveness was assessed score for companies using company strength (in terms of number of years since its establishment) and portfolio strength (based on number of probiotic brands, type of probiotic, target human population, end user and type of ingredient).
More than 500 patents related to probiotics have been filed / granted by the probiotic providers in order to protect the intellectual property generated within this field.
Over the past decade, industry stakeholders have been extensively working towards the development of novel probiotic formulations and products. Recently, the domain has witnessed significant advancements, both in terms of introduction of novel probiotics to support overall well-being and specific health conditions. As a result, a number of patents have been filed / granted to protect the new intellectual capital generated by the probiotic companies engaged in offering various types of probiotics.
During our research, it was observed that majority of the patents filed by probiotic companies in this domain are patent applications (73.6%), followed by those which have been granted approval (26%). Further, majority of the patents (39%) were filed / granted in North America, followed by Asia Pacific (27%). Moreover, despite the large number of patents that have been filed by probiotic companies recently (and hence having a long remaining patent life), only 2% of the total patents have the highest relative valuation.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/probiotics-market.html
Chinese
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek